VEON VEON Ltd. Sponsored ADR

VEON Appoints Anand Ramachandran as Corporate Development Officer

VEON Appoints Anand Ramachandran as Corporate Development Officer

Dubai, March 26, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Group”), today announces the appointment of Anand Ramachandran as Corporate Development Officer, effective from May 1, 2025. Anand will lead VEON’s Mergers & Acquisitions and Investor Relations teams.

Anand joined VEON as Chief of Staff in September 2024, where he led a number of strategic initiatives involving internal, regional and global stakeholders. Prior to joining VEON, Anand was with Singapore Telecom, where he served as Vice President of Business Management in the Group CEO’s Office.

“Anand has already made significant contributions during his successful tenure at VEON, demonstrating strategic expertise and leadership. His nearly three decades of experience in international financial markets and investor relations, which he developed in global investment banks and large telecoms companies, will be extremely beneficial to his new role as we execute on VEON’s strategic initiatives,” said VEON Group CEO Kaan Terzioglu.

“VEON is at a pivotal juncture of growth and innovation and I am excited to be part of this remarkable journey. The Group has a wide range of growth opportunities and I look forward to collaborating with our talented teams and stakeholders to drive sustainable development and further strengthen VEON’s position in the global markets,” said incoming VEON Corporate Development Officer Anand Ramachandran.

About VEON

VEON is a digital operator that provides converged connectivity and digital services to nearly 160 million customers. Operating across six countries that are home to more than 7% of the world’s population, VEON is transforming lives through technology-driven services that empower individuals and drive economic growth. VEON is listed on NASDAQ. For more information visit: 

Disclaimer 

This release contains “forward-looking statements”, as the phrase is defined in Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts, and include statements relating to, among other things, VEON’s corporate strategy and growth opportunities. Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update, except as required by U.S. federal securities laws, any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events.

Contact Information 

Hande Asik 

Group Director of Communications 



 



EN
26/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on VEON Ltd. Sponsored ADR

Chris Hoare
  • Chris Hoare

VEON (Buy, TP: $65/ADR, +18%) Q1 25: Solid quarter, FY25 guidance rei...

VEON has reported a solid set of Q1 results. Underlying top line growth accelerated, driven by almost all the geographies.

 PRESS RELEASE

VEON 1Q25 Earnings Release: Strong Start to 2025, Digital Revenues Su...

VEON 1Q25 Earnings Release: Strong Start to 2025, Digital Revenues Surge 50%, Driving Growth VEON 1Q25 Earnings Release: Strong Start to 2025, Digital Revenues Surge 50%, Driving Growth Dubai, May 15, 2025 VEON 1Q25 Highlights Total revenue growth of 8.9% YoY to USD 1,026 million (12.9% YoY in underlying local currency terms) EBITDA growth of 13.7% YoY to USD 439 million (10.4% YoY in underlying local currency terms) Direct digital revenue growth of 50.2% YoY to USD 147 million (+54.3% YoY in local currency terms), representing 14.3% of revenues for quarterTotal cash and cash equivalent...

 PRESS RELEASE

VEON Joins GSMA Advance’s People Excellence Partner Program as Foundin...

VEON Joins GSMA Advance’s People Excellence Partner Program as Founding Member to Further Professional Skills Development Dubai, May 12, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator, today announces its partnership with GSMA Advance, the learning and skills division of the GSMA, to join the People Excellence Partner program which recognizes and supports organizations committed to upskilling their teams and fostering a culture of knowledge advancement through the GSMA Advance comprehensive suite of learning materials. This collaboration makes VEON the inaugural partner of the ...

 PRESS RELEASE

VEON Shareholders Re-elect Board at 2025 AGM, Founder Augie Fabela to ...

VEON Shareholders Re-elect Board at 2025 AGM, Founder Augie Fabela to Serve as Chairman New York and Dubai, May 8, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or the “Company”), today held its Annual General Meeting (AGM) in New York City at Nasdaq Stock Market, where the Company is listed. With the AGM, the Company’s shareholders approved the recommended slate of seven directors as VEON’s incoming Board of Directors (the “Board”), re-electing the seven directors who served on VEON’s Board in the previous term. VEON welcomes back its founder Augie K Fabela II, Andrei...

 PRESS RELEASE

VEON’s QazCode Signs MoU with Seekr to Develop AI-Powered Solutions to...

VEON’s QazCode Signs MoU with Seekr to Develop AI-Powered Solutions to Drive Digital Growth Dubai and Astana, May 07, 2025:  VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” and together with its subsidiaries, the “Group”), announces that QazCode, its Kazakh software development company, has signed a Memorandum of Understanding (MoU) with Seekr, an artificial intelligence (AI) technology provider, to develop and implement AI-powered business-to-business (B2B) solutions across QazCode’s operations. To accelerate its development of augmented intelligence solutions for use across ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch